Icona HomeTown

1.3 by Emory University


Dec 2, 2022

Informazioni su HomeTown

Gestisci il tuo protocollo di predisposizione al cancro complesso

Born out of Emory University and Children's Healthcare of Atlanta (CHOA), the HomeTown Manager App is built to help you stay on track of the proactive and targeted surveillance needed. The app supports 6 predispositions:

1. Hereditary Pheochromocytoma Paraganglioma Syndrome (HPPS)

2. Familial Adenomatous Polypopsis (FAP)

3. Li Fraumeni Syndrome (LFS)

4. DICER1

5. Von Hippel-Lindau Syndrome (VHL)

6. Lynch Syndrome

Our focus is to help the caretaker of the family with management of these predispositions. To create this app we interviewed families with 1 to 4 family members with the predisposition. We learned that making sure everybody sticks to the protocol can be challenging: different kids' protocols, many appointments, keeping track of results, and a lot of stress. HomeTown's intention is to centralize that on an app to make your life a bit easier.

Disclaimer: please remember to seek a doctor's advice in addition to using this app before making any medical decisions.

Novità nell'ultima versione 1.3

Last updated on Dec 2, 2022

Welcome to the HomeTown cancer predisposition manager!

Features and Fixes
1. [Visual Bug] Issues with Reminders page
2. [Visual Bug] Text is top aligned in Surveillance Protocol Review page

Analytics: Prod

Traduzione in caricamento...

Informazioni APP aggiuntive

Ultima versione

Richiedi aggiornamento HomeTown 1.3

Caricata da

Soe Khant Win

È necessario Android

Android 7.0+

Available on

Ottieni HomeTown su Google Play

Mostra Altro

HomeTown Screenshot

Commento Loading...
Lingua
Ricerca...
Iscriviti ad APKPure
Sii il primo ad accedere alla versione anticipata, alle notizie e alle guide dei migliori giochi e app Android.
No grazie
Iscrizione
Abbonato con successo!
Ora sei iscritto ad APKPure.
Iscriviti ad APKPure
Sii il primo ad accedere alla versione anticipata, alle notizie e alle guide dei migliori giochi e app Android.
No grazie
Iscrizione
Successo!
Ora sei iscritto alla nostra newsletter.